Latest filing published 16 Apr 2018 for Oncotelic Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -62.9%Entry US$0.35 · Close at T+365 US$0.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Donald Rogers Reynolds: trading record in brief
Donald Rogers Reynolds appears in our data through filings on Oncotelic Therapeutics, Inc. shares, published by SEC (Form 4). Between 16 December 2016 and 12 April 2018, the trades on record add up to 4 filings.
The open-market record is one-sided, with 4 purchases worth €10k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2018 to date brings 1 purchase and no sales.
Half of the purchases are above €3,390 and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +82.9%. Past outcomes like these are no guarantee of what comes next.
On 16 April 2018 came the latest disclosure, an open-market purchase in Oncotelic Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Donald Rogers Reynolds
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 sharesCommon StockSEC:0001209191-18-024991:0Canonical exit: 11 Jul 2018 (T+90)
- 12,700 shares@ US$0.3441.4% of flowCommon Stock, $.01 par value per shareSEC:0001209191-16-156108:0Canonical exit: 16 Mar 2017 (T+90)
- 7,350 shares@ US$0.3524.7% of flowCommon Stock, $.01 par value per shareSEC:0001209191-16-156108:1Canonical exit: 16 Mar 2017 (T+90)
- 9,950 shares@ US$0.35533.9% of flowCommon Stock, $.01 par value per shareSEC:0001209191-16-156108:2Canonical exit: 16 Mar 2017 (T+90)
4 of 4 declarations
